Literature DB >> 9836488

The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic.

P Cook-Mozaffari1, R Newton, V Beral, D P Burkitt.   

Abstract

Estimated incidence rates are presented for three human immunodeficiency virus (HIV)-associated cancers [Kaposi's sarcoma (KS), Burkitt's lymphoma (BL) and other non-Hodgkin's lymphomas (NHLs)] from across the African continent, based on data collected before the HIV epidemic. Mapping of the rates and comparisons with a range of geographical variables indicate completely different distributions for KS and BL but a degree of similarity in the occurrence of Burkitt's lymphoma and other NHLs. Comparisons with rates elsewhere in the world suggest, most notably, that KS was as common in some regions of sub-Saharan Africa as was cancer of the colon in much of Western Europe. Comparison with data from the era of AIDS indicates 20-fold increases in the occurrence of Kaposi's sarcoma in Uganda and Zimbabwe. The highest rates for BL were three to four times the rates for leukaemia at young ages in Western populations, but the general incidence of other NHL was no higher than in the West and very low rates were indicated for much of southern Africa.

Entities:  

Mesh:

Year:  1998        PMID: 9836488      PMCID: PMC2063225          DOI: 10.1038/bjc.1998.717

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  The pattern of adult medical admissions in Addis Ababa, Ethiopia.

Authors:  F T Lester; E Tsega
Journal:  East Afr Med J       Date:  1976-11

2.  Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes.

Authors:  A G OETTLE
Journal:  Acta Unio Int Contra Cancrum       Date:  1962

3.  Soft tissue tumours.

Authors:  A C Templeton
Journal:  Recent Results Cancer Res       Date:  1973

Review 4.  Etiology of Burkitt's lymphoma--an alternative hypothesis to a vectored virus.

Authors:  D P Burkitt
Journal:  J Natl Cancer Inst       Date:  1969-01       Impact factor: 13.506

5.  Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS.

Authors:  H R Wabinga; D M Parkin; F Wabwire-Mangen; J W Mugerwa
Journal:  Int J Cancer       Date:  1993-04-22       Impact factor: 7.396

6.  Cancer in the African population of Harare, Zimbabwe, 1990-1992.

Authors:  M T Bassett; E Chokunonga; B Mauchaza; L Levy; J Ferlay; D M Parkin
Journal:  Int J Cancer       Date:  1995-09-27       Impact factor: 7.396

7.  The distribution of non-Burkitt, non-Hodgkin's lymphomas in Uganda in relation to malarial endemicity.

Authors:  R Schmauz; J W Mugerwa; D H Wright
Journal:  Int J Cancer       Date:  1990-04-15       Impact factor: 7.396

8.  Cancer in Rwanda.

Authors:  R Newton; P J Ngilimana; A Grulich; V Beral; B Sindikubwabo; A Nganyira; D M Parkin
Journal:  Int J Cancer       Date:  1996-03-28       Impact factor: 7.396

9.  Kaposi's sarcoma in England and Wales before the AIDS epidemic.

Authors:  A E Grulich; V Beral; A J Swerdlow
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

10.  Classical Kaposi's sarcoma in north-east Sardinia: an overview from 1977 to 1991.

Authors:  F Cottoni; R De Marco; M A Montesu
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

View more
  50 in total

1.  Sex and geographic patterns of human herpesvirus 8 infection in a nationally representative population‐based sample in Uganda.

Authors:  Benon Biryahwaho; Sheila C Dollard; Ruth M Pfeiffer; Fatma M Shebl; Stella Munuo; Minal M Amin; Wolfgang Hladik; Ruth Parsons; Sam M Mbulaiteye
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

2.  Ultraviolet Radiation and Kaposi Sarcoma Incidence in a Nationwide US Cohort of HIV-Infected Men.

Authors:  Elizabeth K Cahoon; Eric A Engels; D Michal Freedman; Mary Norval; Ruth M Pfeiffer
Journal:  J Natl Cancer Inst       Date:  2016-12-31       Impact factor: 13.506

3. 

Authors:  A Amor; M Sánchez-Conde
Journal:  Medicine (Madr)       Date:  2009-01-06

4.  Non AIDS Kaposi's Sarcoma Leading to Lower Extremities Wounds, Case Presentations and Discussion.

Authors:  Laemthong Phavixay; David Raynolds; Richard Simman
Journal:  J Am Coll Clin Wound Spec       Date:  2013-01-19

Review 5.  Kaposi sarcoma.

Authors:  Ethel Cesarman; Blossom Damania; Susan E Krown; Jeffrey Martin; Mark Bower; Denise Whitby
Journal:  Nat Rev Dis Primers       Date:  2019-01-31       Impact factor: 52.329

6.  Similar Immunological Profiles Between African Endemic and Human Immunodeficiency Virus Type 1-Associated Epidemic Kaposi Sarcoma (KS) Patients Reveal the Primary Role of KS-Associated Herpesvirus in KS Pathogenesis.

Authors:  Salum J Lidenge; For Yue Tso; Owen Ngalamika; John R Ngowi; Yasaman Mortazavi; Eun Hee Kwon; Danielle M Shea; Veenu Minhas; Julius Mwaiselage; Charles Wood; John T West
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

7.  Multiple oncogenic viruses identified in Ocular surface squamous neoplasia in HIV-1 patients.

Authors:  Kenneth O Simbiri; Masanao Murakami; Michael Feldman; Andrew P Steenhoff; Oathokwa Nkomazana; Gregory Bisson; Erle S Robertson
Journal:  Infect Agent Cancer       Date:  2010-03-26       Impact factor: 2.965

8.  Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress.

Authors:  Zhiqiang Qin; Eduardo Freitas; Roger Sullivan; Sarumathi Mohan; Rocky Bacelieri; Drake Branch; Margaret Romano; Patricia Kearney; Jim Oates; Karlie Plaisance; Rolf Renne; Johnan Kaleeba; Chris Parsons
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

9.  Impact of infection with human immunodeficiency virus-1 (HIV) on the risk of cancer among children in Malawi - preliminary findings.

Authors:  Nora Mutalima; Elizabeth M Molyneux; William T Johnston; Harold W Jaffe; Steve Kamiza; Eric Borgstein; Nyengo Mkandawire; George N Liomba; Mkume Batumba; Lucy M Carpenter; Robert Newton
Journal:  Infect Agent Cancer       Date:  2010-02-12       Impact factor: 2.965

10.  Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi's sarcoma.

Authors:  Francesca Cainelli; Alfredo Vallone
Journal:  Biologics       Date:  2009-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.